ADAR1 Capital Management »

Gossamer Bio shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Gossamer Bio (GOSS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $865k 733k 1.18
2023-12-31 $651k 713k 0.91

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Gossamer Bio

NEA Management Company
Siren
Vanguard Group
Octagon Capital Advisors
Arch Venture Corp
T. Rowe Price Associates
Palo Alto Investors
Samsara BioCapital
683 Capital Management
Alyeska Investment Group
Silverarc Capital Management
Hillhouse Capital Advisors
Acadian Asset Management
Monaco Asset Management SAM
Opaleye Management

View all funds holding Gossamer Bio